A new TGF-β3 controlled-released chitosan scaffold for tissue engineering synovial sheath

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Flexor tendon healing is often complicated by adhesions, limiting joint range of motion.
• Peritendinous adhesion formation remains a significant challenge in tendon repair.
• Transforming growth factor-β3 (TGF-β3) shows potential in reducing adhesion formation.

Purpose of the Study:

• To design and evaluate a novel tissue-engineered synovial sheath for preventing flexor tendon adhesions.
• To achieve controlled release of TGF-β3 for enhanced tendon healing outcomes.
• To combine controlled protein delivery with tissue engineering for improved post-operative results.

Main Methods:

• Chitosan microspheres were prepared for stable TGF-β3 delivery.
• A 3D chitosan scaffold was fabricated and loaded with TGF-β3 microspheres.
• Synovial cells were cultured and seeded onto the scaffold to create a tissue-engineered sheath.
• Scaffold structure, TGF-β3 release, and cell compatibility were assessed.

Main Results:

• The developed scaffold demonstrated good structural integrity.
• The scaffold exhibited excellent compatibility with cultured synovial cells.
• The system facilitates controlled release of TGF-β3.
• This combinative strategy shows feasibility for tendon repair applications.

Conclusions:

• A novel tissue-engineered synovial sheath loaded with TGF-β3 was successfully developed.
• The scaffold supports controlled protein release and cell integration, offering a promising approach.
• This strategy holds potential for preventing flexor tendon adhesions and improving functional recovery.